H-1B sponsorship profile: QLD Biotherapeutics Inc. Across U.S. Department of Labor LCA disclosures, QLD Biotherapeutics Inc filed 4 Labor Condition Applications covering 4 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (4 certified of 4 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on QLD Biotherapeutics Inc’s H-1B petitions range from $72,100 at the low end to $120,000 at the high end, with a petition-weighted average of $99,275. That range reflects the mix of occupations the company sponsors, led by Scientist I (1 petitions at $120,000 avg), followed by Research Scientist and Biotech Project Management Specialist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. QLD Biotherapeutics Inc is headquartered in Boston, MA under NAICS code 541715, and places H-1B workers across 1 state, most heavily in MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where QLD Biotherapeutics Inc ranks. By H-1B petition volume, QLD Biotherapeutics Inc is #30,742 of 119,880 employers nationally and #1,400 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.